FMR LLC Files Schedule 13G Regarding Xenon Pharmaceuticals
FMR LLC has filed a Schedule 13G form indicating a change in its ownership stake in Xenon Pharmaceuticals.
Stocks · News reference
US Stocks Mixed; Industrial Production Unchanged In August
U.S. stocks mixed Friday: Nasdaq and S&P 500 edged higher, Dow slipped. Oil rose; industrial production was flat, while GIPR and IMCC surged.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
IM Cannabis Announces Closing of US$1.2 Million Convertible Note Financing
IM Cannabis Corp. closed a US$1.2 million convertible note financing with an existing institutional investor, featuring a 15% original issuance discount and warrants for 3,936,330 shares.
Xenon Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Xenon Pharmaceuticals Inc. announced that it will present at four investor conferences during the fourth quarter of 2026.
Generation Income Properties Identified Among Most-Shorted Small-Cap REITs
Generation Income Properties (GIPR) was reported as one of the five most-shorted micro- and small-cap REITs with a market capitalization under $2 billion.
Xenon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
Xenon Pharmaceuticals Inc. announced it will release its financial results for the third quarter of 2026 and provide a business update after the market close on November 9, 2026.
IM Cannabis Registers to Sell 2.8M Common Shares for Holders
IM Cannabis Corp. has filed a registration statement to facilitate the potential sale of 2.8 million common shares by existing security holders.